comparemela.com

Latest Breaking News On - Avalo therapeutics daily - Page 1 : comparemela.com

Short Interest in Avalo Therapeutics, Inc (NASDAQ:AVTX) Declines By 20 3%

Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 83,100 shares, a drop of 20.3% from the April 30th total of 104,300 shares. Based on an average trading volume of 658,200 shares, the days-to-cover ratio is currently 0.1 […]

Short Interest in Avalo Therapeutics, Inc (NASDAQ:AVTX) Decreases By 32 0%

Short Interest in Avalo Therapeutics, Inc (NASDAQ:AVTX) Decreases By 32 0%
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Avalo Therapeutics (NASDAQ:AVTX) Trading Down 2 9%

Avalo Therapeutics (NASDAQ:AVTX) Trading Down 2 9%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Avalo Therapeutics, Inc (NASDAQ:AVTX) Short Interest Up 23 8% in December

Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 12,640,000 shares, a growth of 23.8% from the November 30th total of 10,210,000 shares. Based on an average trading volume of 51,393,300 shares, the short-interest ratio […]

Avalo Therapeutics (AVTX) Scheduled to Post Earnings on Wednesday

Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) will be announcing its earnings results on Wednesday, August 2nd. Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) last released its earnings results on Thursday, May 4th. The company reported ($0.85) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.97) by $0.12. The firm had […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.